drugset / Trial / NCT04637152
Sacubitril/Valsartan in Resistant Hypertension
Phase 2
Completed
80 enrolled
Hospital Geral Roberto Santos
Hospital Universitário Professor Edgard Santos · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The present study aims to evaluate the antihypertensive effect of sacubitril/valsartan in patients with resistant hypertension compared to the use of recommended and optimized antihypertensive therapy, through a randomized clinical trial, over 12 weeks.
Timeline
- Start
- 2020-11-11
- Primary completion
- 2022-07-22
- Completion
- 2022-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sacubitril-Valsartan | Unknown | 97 mg | Oral |
| Subject | Sacubitril-Valsartan | Unknown | 103 mg | Oral |